A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 6,859 shares of PFE stock, worth $172,366. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,859
Previous 7,595 9.69%
Holding current value
$172,366
Previous $213 Million 6.59%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $20,387 - $23,103
-736 Reduced 9.69%
6,859 $198 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $4,849 - $5,683
-192 Reduced 2.47%
7,595 $213 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $27,857 - $31,989
1,076 Added 16.03%
7,787 $216 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $175,358 - $227,771
6,711 New
6,711 $193 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.